APPLIED BIOCODE CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.8 TWD | -0.50% |
|
-1.00% | -21.74% |
| 04-15 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
| 03-21 | Applied BioCode Announces CEO Changes | CI |
Evolution of the average Target Price on Applied BioCode Corporation
Price target over the last 5 years
History of analyst recommendation changes
d7ac18465430e4652cd8c9b07.mCcVvMzDoVncSdAKRb82OghXjk65-LU4RZhaRo_Cocs.r1Vw_o-R7TXlOqgnEv14Uj8N3S_NrtpWcd4sc86L95m1TE2KlYbuauo6ow~80da50473e3b929835eed77f5540b317
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
19.8
TWD
Average target price
22
TWD
Spread / Average Target
+11.11%
High Price Target
22
TWD
Spread / Highest target
+11.11%
Low Price Target
22
TWD
Spread / Lowest Target
+11.11%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 6598 Stock
- Consensus Applied BioCode Corporation